Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Franziska Wachter, M.D.

Concepts (140)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Franziska Wachter's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Franziska Wachter has written about over time.
Vincristine, 3 publications between 2012 and 2013, average publication date March 2013. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 5 publications between 2011 and 2023, average publication date July 2014. Tumor Suppressor Protein p53, 5 publications between 2011 and 2019, average publication date September 2014. Proto-Oncogene Proteins c-bcl-2, 4 publications between 2012 and 2017, average publication date September 2015. bcl-2-Associated X Protein, 2 publications between 2015 and 2017, average publication date April 2016. Peptides, Cyclic, 1 publications between 2016 and 2016, average publication date October 2016. Leukemia, Myeloid, Acute, 2 publications between 2011 and 2024, average publication date November 2017. Proto-Oncogene Proteins c-mdm2, 2 publications between 2016 and 2019, average publication date December 2017. Proto-Oncogene Proteins, 4 publications between 2015 and 2021, average publication date May 2018. Anemia, Hemolytic, Autoimmune, 1 publications between 2021 and 2021, average publication date February 2021. Parvoviridae Infections, 1 publications between 2021 and 2021, average publication date February 2021. Neoplasms, Muscle Tissue, 1 publications between 2021 and 2021, average publication date November 2021. Oncogene Proteins, Fusion, 1 publications between 2021 and 2021, average publication date November 2021. Proteins, 1 publications between 2021 and 2021, average publication date November 2021. Protein-Tyrosine Kinases, 1 publications between 2021 and 2021, average publication date November 2021. Leukemoid Reaction, 1 publications between 2022 and 2022, average publication date May 2022. Graft vs Host Disease, 1 publications between 2023 and 2023, average publication date June 2023. Hematopoietic Stem Cell Transplantation, 1 publications between 2023 and 2023, average publication date June 2023. Hematopoietic Stem Cells, 1 publications between 2024 and 2024, average publication date February 2024.

To see the data from this visualization as text, click here.
Wachter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (38)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.